Search
Searching Content indexed under Food and Drugs Law by Marks & Clerk ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Business Intelligence Q3 2019
Welcome to the latest edition of Business Intelligence. To view the online version of this magazine, please follow this link.
UK
22 Aug 2019
2
Brand Protection Essential As Scotland Aims To Be A Good Food Nation
Scotland's reputation for world-beating food and drink continues to grow and it is vital we celebrate the outstanding contributions of all producers – from household names to small artisan companies.
UK
21 Jun 2019
3
The Five Legal Pitfalls Of Clinical Trials Agreements
Collaboration between pharmaceutical companies, research organisations and hospital trusts, and the resulting clinical trials of new products and processes are an essential part of getting new drugs to market.
UK
13 Jun 2019
4
How McDonald's Lost Its Big Mac Trade Mark
How did Irish burger chain Supermac's manage to get the Big Mac trade mark cancelled across the EU? The answer lies in the lack of evidence presented by McDonald's as Daniel Bailey explains.
UK
28 Jan 2019
5
Distillers' Secure Method Of Product Provenance
It's clear that Scottish distilling has refused to rest on its laurels in 2018, continuously taking traditional techniques and marrying them to startling innovation.
UK
24 Jan 2019
6
Beyond Pharma: The Role Of Medtech In Antimicrobial Resistance
A major review published by the World Health Organisation threw the spotlight once again on the issue of antimicrobial resistance (AMR) and the ongoing misuse of antibiotics around the world.
UK
8 Jan 2019
7
Intellectual Property In A 'No-Deal' Brexit: What Can We Expect?
While a draft Brexit deal is now on the table, question marks remain over whether it can be delivered. As such, the sensible course of action for intellectual property rights owners remains to plan for a potential 'no-deal' Brexit.
UK
30 Nov 2018
8
What Impact Would A 'No-Deal' Brexit Have On Community Plant Variety Rights (CPVR)?
On Friday, the UK government issued guidance on the effect of a no-deal Brexit on Community Plant Variety Rights (CPVR) and seed and propagating material.
UK
17 Oct 2018
9
The European Commission's "Export Manufacturing Waiver" To SPCs – Changing The Dynamics For Day One Launches?
The aim of SPCs is therefore to compensate drug companies for this loss of effective patent protection.
European Union
19 Jul 2018
10
3D Printing And Medtech: The IP Challenge
At present, 3D printing – or additive manufacturing – struggles to compete with traditional methods of mass production on price.
UK
27 Apr 2018
11
"Plausibility" Bar Rises With EPO's Ruling On Anti-Cancer Drug Dasatinib
When the Boards of Appeal of the European Patent Office revoked European patent number EP1169038 protecting the anti-cancer drug dasatinib (Sprycel®) back in February 2017...
UK
14 Aug 2017
12
Pharmaceutical Patent Rights Get A Boost In Canada Under CETA-Driven Legislation
After years of negotiations, the CETA between Canada and Europe was finally approved by all 28 European Union member states on October 28, 2016...
Canada
18 Nov 2016
13
Tomatoes II Returns To The EPO's Technical Board Of Appeal
The TBA decided to remit the decision to the Opposition Division with the order to maintain the patent, EP1211926, on the basis of auxiliary request I, claim 1 of which is reproduced below.
UK
16 Nov 2016
14
Parallel Importation Of Pharmaceutical Products
The question of parallel importation of pharmaceutical products has recently been considered by the Chancery Division of the UK's High Court in the case of Flynn Pharma Limited v Drugsrus Limited and Others.
UK
11 Jul 2016
15
Implications Of The TPP In Canada
On 5 October 2015, Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States, and Vietnam, entered into a landmark trade agreement known as the Trans-Pacific Partnership (TPP).
Canada
3 Dec 2015
16
Warner-Lambert v Actavis: Indirect Infringement And Swiss Form Claims
The litigation concerns Warner-Lambert's prescription-only drug pregabalin, which it markets under the trade name LYRICA and which is prescribed to treat epilepsy, generalised anxiety disorder and neuropathic pain.
UK
1 Jul 2015
Links to Result pages
 
1